Atlas Trials

A Study on the Accurate Evaluation of Pseudoprogression of Rectal Cancer Immunotherapy Based on Multitemporal and Multiparameter MRI

Clinical trial NCT07381322 · RECRUITING

Trial details

NCT number
NCT07381322
Sponsor
Peiyi Xie
Status
RECRUITING
Study type
OBSERVATIONAL
Rectal Cancer
Start date
2026-02-01
Primary completion
2029-12-31
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.